Contact Us | Directions | Referring a Patient

A leading comprehensive brain tumor program, using molecular diagnostic, gene expression analysis,
cutting edge clinical trials and advanced medical informatics to customize treatment plans for cancer patients.
 Latest Headlines
This Young Woman's Migraines Turned Out to be a Brain Tumor
Thu, 11 Feb 2016 21:21:53 GMT (Yahoo Health)
Newtown's Justin Bogdanoff overcame brain tumor, vision issues to wrestle
Thu, 11 Feb 2016 21:12:43 GMT (SportzEdge.com)
Why I decided to watch my brain tumor, not treat it right away
Wed, 10 Feb 2016 20:28:05 GMT (The Seattle Times)
Visualase for Brain Tumors
Thu, 11 Feb 2016 23:19:54 GMT (KSAT San Antonio)
Barrow Brain and Spine discusses brain tumors
Wed, 10 Feb 2016 14:51:28 GMT (ABC15 Arizona)
Woman Suffering From Migraine Headaches Finds She Had a Brain Tumor
Wed, 10 Feb 2016 20:02:53 GMT (The Epoch Times)
'Little Psy' dies of brain tumor
Thu, 11 Feb 2016 19:12:49 GMT (The Korea Times US)
A stranger, a brain tumor and a request for prayer | Moms
Tue, 09 Feb 2016 19:53:00 GMT (NRToday.com)
Praying for a miracle: Auburn student battles brain tumor
Thu, 04 Feb 2016 14:35:59 GMT (AL.com)
Why I let a brain tumor go untouched for 10 years
Mon, 01 Feb 2016 16:06:10 GMT (Washington Post)

* Headlines are from industry sponsored news wires, medical journals and established news organizations from around the world . Please consider the source of the content when viewing the story.
  
 
16th Annual UCLA Brain Tumor Conference
March 11th-12th 2016


Join brain cancer survivors, family members, friends and health care professionals at the 2016 UCLA Brain Tumor Conference, hosted by the UCLA Neuro-Oncology Program.

This FREE conference will offer participants the opportunity to hear leading healthcare professionals speak about the latest treatments for brain tumors. Through this conference, the Neuro-Oncology Program promotes the sharing of information and experience between brain tumor survivors, their families, friends and health care professionals.

Registration opens Feb 13, 2016: more information.


Dani Saleh Brain Cancer Research Fund at UCLA


The Dani Saleh Brain Cancer Research Fund supports the brain cancer research collaboration between Dr. Timothy Cloughesy and Dr. Stan Nelson. This fund will directly support the work and training of a research fellow in Dr. Stan Nelson’s lab.

Dr. Nelson is Professor and Vice Chair of Human Genetics and Professor of Psychiatry at the David Geffen School of Medicine at UCLA.

UCLA Neuro-Oncology & SiliconMED Launch Online Tool Correlating Gene Expression Levels with Overall Survival of Brain Cancer Patients

Genomic analysis is a powerful new tool permitting unprecedented insights into how brain tumors form and has been enabled primarily through microarray technology. ProbeSetAnalyzer.com, a new web based tool, is aiming to help clinicians and researchers take the massive amount of data created by microarrays and better visualize gene expression levels and how they relate to the overall survival of brain cancer patients.

Most Popular
. Clinical Trials
. Probe Set Analyzer
. Our Team
. Brain Tumor Translational Resource
. Art of the Brain
. Personalized Medicine using Targeted Molecular Therapy
. Online Giving
. How our Glioblastoma Multiforme Patients Perform
Neuro-Oncology on Facebook

Spring/Summer 2014
UCLA Neuro-Oncology : Breakthroughs Spotlighting new discovery in brain cancer research.



It is time to include patients with brain tumors in phase I trials in oncology.
J Clin Oncol.


Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab.
Neuro Oncol.


Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma.
Neuro Oncol.


Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.
J Neurooncol.


Phase II study of aflibercept in recurrent malignant glioma: a north american brain tumor consortium study.
J Clin Oncol.



All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.

Portions Copyright (Search, Chart, Content Publishing Tools, Photography, ProviderIQ) 1998-2016 SiliconMED North America

ProviderIQ is a registered trademark of SiliconMED North America and used by permission.

Copyright © 2016 UCLA Neuro-Oncology Program | Timothly Cloughesy MD; Director
All Rights Reserved.

[Content Published:2/12/2016 3:17:02 AM PST]